The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease
Open accessAbstract
BACKGROUND: Diffusion tensor imaging (DTI) is a promising method for identifying significant cross-sectional differences of white-matter tracts in normal controls (NC) and those with mild cognitive impairment (MCI) or Alzheimer's disease (AD). There have not been many studies establishing its longitudinal utility. METHODS: Seventy-five participants (25 NC, 25 amnestic MCI, and 25 AD) had 3-Tesla MRI scans and clinical evaluations at baseline and 3, 6, and 12 months. Fractional anisotropy (FA) and mean diffusivity (MD) were analyzed at each time-point and longitudinally in eight a priori-selected areas taken from four regions of interest (ROIs). RESULTS: Cross-sectionally, MD values were higher, and FA values lower in the fornix and splenium of the AD group compared with either MCI or NC (P < .01). Within-group change was more evident in MD than in FA over 12 months: MD increased in the inferior, anterior cingulum, and fornix in both the MCI and AD groups (P < .01). CONCLUSIONS: There were stable, cross-sectional, region-specific differences between the NC and AD groups in both FA and MD at each time-point over 12 months. Longitudinally, MD was a better indicator of change than FA. Significant increases of fornix MD in the MCI group suggest this is an early indicator of progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For all analyses, we used mean diffusivity as our primary DTI measure in autosomal-dominant Alzheimer’s disease, since previous studies found mean diffusivity to be the most sensitive DTI marker to detect fibre tract alterations (Clerx et al., 2012; Nowrangi et al., 2013).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Nowrangi et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Models for Longitudinal Data: A Generalized Estimating Equation Approach
Zeger, S. L., Liang, K., & Albert, P. S. (1988) · Biometrics · doi:10.2307/2531734 · Cited by 4,505
Research works printed but not linked: 1
- Zhang Y, 2007, Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease, Neurology, 68, 13, 10.1212/01.wnl.0000250326.77323.01 · DOI
Cited by
Sorted by citations
Brain atrophy in Alzheimer’s Disease and aging
Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., Galluzzi, S., Marizzoni, M., & Frisoni, G. B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.002 · Cited by 836
Amlien, I. K., & Fjell, A. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.017 · Cited by 219
White-matter integrity on DTI and the pathologic staging of Alzheimer’s disease
Kantarci, K., Murray, M. E., Schwarz, C. G., Reid, R. I., Przybelski, S. A., Lesnick, T., Zuk, S. M., Raman, M. R., Senjem, M. L., Gunter, J. L., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.04.024 · Cited by 205
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
Araque Caballero, M. Á., Suárez-Calvet, M., Duering, M., Franzmeier, N., Benzinger, T., Fagan, A. M., Bateman, R. J., Jack, C. R., Levin, J., Dichgans, M., et al. (2018) · Brain · doi:10.1093/brain/awy229 · Cited by 184
“For all analyses, we used mean diffusivity as our primary DTI measure in autosomal-dominant Alzheimer’s disease, since previous studies found mean diffusivity to be the most sensitive DTI marker to detect fibre tract alterations (Clerx et al., 2012; Nowrangi et al., 2013).”
MethodLongitudinal changes in microstructural white matter metrics in Alzheimer's disease
Mayo, C. D., Mazerolle, E. L., Ritchie, L. J., Fisk, J. D., & Gawryluk, J. R. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.012 · Cited by 159
Chen, Y., Wang, Y., Song, Z., Fan, Y., Gao, T., & Tang, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101911 · Cited by 152
Relationship Between DTI Metrics and Cognitive Function in Alzheimer’s Disease
Mayo, C. D., García-Barrera, M. A., Mazerolle, E. L., Ritchie, L. J., Fisk, J. D., Gawryluk, J. R., & Initiative, A. D. N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00436 · Cited by 154
Afzal, S., Maqsood, M., Nazir, F., Khan, U. M., Aadil, F., Awan, K. M., Mehmood, I., & Song, O.-Y. (2019) · IEEE Access · doi:10.1109/access.2019.2932786 · Cited by 149
Aderghal, K., Khvostikov, A. V., Крылов, А., Benois‐Pineau, J., Afdel, K., & Catheline, G. (2018) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2018.00067 · Cited by 154
Praet, J., Manyakov, N. V., Muchene, L., Mai, Z., Terzopoulos, V., de Backer, S., Torremans, A., Guns, P.-J., Van De Casteele, T., Bottelbergs, A., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0329-8 · Cited by 133
Cerebral atrophy in mild cognitive impairment: A systematic review with meta‐analysis
Tabatabaei‐Jafari, H., Shaw, M. E., & Cherbuin, N. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.002 · Cited by 128
Douet, V., & Chang, L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00343 · Cited by 122
Aderghal, K., Afdel, K., Benois‐Pineau, J., & Catheline, G. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05652 · Cited by 106
Diffusion-MRI in neurodegenerative disorders
Goveas, J., O’Dwyer, L., Mascalchi, M., Cosottini, M., Diciotti, S., De Santis, S., Passamonti, L., Tessa, C., Toschi, N., & Giannelli, M. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.04.006 · Cited by 104
Longitudinal diffusion tensor imaging in frontotemporal dementia
Mahoney, C. J., Simpson, I. J. A., Nicholas, J. M., Fletcher, P. D., Downey, L. E., Golden, H. L., Clark, C. N., Schmitz, N., Rohrer, J. D., Schott, J. M., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24296 · Cited by 101
Schuster, C., Elamin, M., Hardiman, O. M., & Bede, P. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309888 · Cited by 89
Kantarci, K., Schwarz, C. G., Reid, R. I., Przybelski, S. A., Lesnick, T. G., Zuk, S. M., Senjem, M. L., Gunter, J. L., Lowe, V., Machulda, M. M., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1482 · Cited by 88
The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
Nowrangi, M. A., & Rosenberg, P. B. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00001 · Cited by 87
Identifying Early Mild Cognitive Impairment by Multi-Modality MRI-Based Deep Learning
Li, K., Jiang, J., Huang, J., & Zhang, T. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00206 · Cited by 87
Pohl, K. M., Sullivan, E. V., Rohlfing, T., Chu, W., Kwon, D., Nichols, B. N., Zhang, Y., Brown, S. A., Tapert, S. F., Cummins, K., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.01.061 · Cited by 85
Chao, L. L., DeCarli, C. S., Kriger, S., Truran, D., Zhang, Y., Laxamana, J., Villeneuve, S., Jagust, W. J., Sanossian, N., Mack, W. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065175 · Cited by 85
A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
Lawrence, E., Vegvari, C., Ower, A. K., Hadjichrysanthou, C., de Wolf, F., & Anderson, R. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170261 · Cited by 89
Dissecting the Fornix in Basic Memory Processes and Neuropsychiatric Disease: A Review
Benear, S. L., Ngo, C. T., & Olson, I. R. (2020) · Brain Connectivity · doi:10.1089/brain.2020.0749 · Cited by 95
Yu, J., Lam, C. L. M., & Lee, T. M. C. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.026 · Cited by 81
Galluzzi, S., Marizzoni, M., Babiloni, C., Albani, D., Antelmi, L., Bagnoli, C., David Bartrés-faz, A., Cordone, S., Didic, M., Farotti, L., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12482 · Cited by 76
Zhao, H., Zhou, X., Song, Y., Zhao, W., Sun, Z., Zhu, J., & Yu, Y. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01683-0 · Cited by 85
Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C. R., Sperling, R., Cummings, J., Blennow, K., et al. (2014) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.32 · Cited by 67
Advances in MRI Biomarkers for the Diagnosis of Alzheimer’s Disease
Kehoe, E. G., McNulty, J. P., Mullins, P. G., & Bokde, A. L. W. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.42 · Cited by 70
White Matter Microstructural Damage as an Early Sign of Subjective Cognitive Decline
Luo, C., Li, M., Qin, R., Chen, H., Yang, D., Huang, L., Liu, R., Xu, Y., Bai, F., & Zhao, H. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00378 · Cited by 59
Neuroimaging in aging and neurologic diseases
Risacher, S. L., & Saykin, A. J. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00012-1 · Cited by 56
Arendash, G. W., Cao, C., Abulaban, H., Baranowski, R., Wisniewski, G., Becerra, L. R., Andel, R., Lin, X., Zhang, X., Wittwer, D., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190367 · Cited by 52
Ray, N. J., Metzler-Baddeley, C., Khondoker, M. R., Grothe, M. J., Teipel, S., Wright, P., Heinsen, H., Jones, D. K., Aggleton, J. P., & O'Sullivan, M. J. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3617-14.2015 · Cited by 48
Caso, F., Agosta, F., & Filippi, M. (2015) · Neurodegenerative Diseases · doi:10.1159/000441422 · Cited by 47
Rabin, J. S., Perea, R. D., Buckley, R. F., Neal, T. E., Buckner, R. L., Johnson, K. A., Sperling, R. A., & Hedden, T. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy031 · Cited by 53
Balachandar, R., John, J. P., Saini, J. S., Kumar, K. J., Joshi, H., Sadanand, S., Aiyappan, S., Sivakumar, P. T., Loganathan, S., Varghese, M., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4168 · Cited by 51
Sole, A. D. (2016) · Functional Neurology · doi:10.11138/fneur/2016.31.4.205 · Cited by 49
Gyebnár, G., Szabó, Á., Sirály, E., Fodor, Z., Sákovics, A., Salacz, P., Hidasi, Z., Csibri, É., Rudas, G., Kozák, L. R., et al. (2018) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2017.10.007 · Cited by 49
Zhao, J., Ding, X.-T., Du, Y.-H., Wang, X., & Men, G. (2019) · Brain and Behavior · doi:10.1002/brb3.1407 · Cited by 43
Qin, Y.-Y., Li, M.-W., Zhang, S., Zhang, Y., Zhao, L.-Y., Lei, H., Oishi, K., & Zhu, W.-Z. (2013) · Neuroradiology · doi:10.1007/s00234-013-1195-0 · Cited by 42
Self-citationMicrostructural brain changes track cognitive decline in mild cognitive impairment
Reas, E. T., Hagler, D. J., White, N. S., Kuperman, J. M., Bartsch, H., Wierenga, C. E., Galasko, D. R., Brewer, J. B., Dale, A. M., & McEvoy, L. K. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.09.027 · Cited by 39
Weiler, M., Agosta, F., Canu, E., Copetti, M., Magnani, G., Marcone, A., Pagani, E., Balthazar, M. L. F., Comı, G., Falini, A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150196 · Cited by 40
White matter changes from mild cognitive impairment to Alzheimer’s disease: a meta-analysis
Qin, L., Guo, Z., McClure, M. A., & Mu, Q. (2020) · Acta Neurologica Belgica · doi:10.1007/s13760-020-01322-5 · Cited by 41
Hartmann, C. J., Wojtecki, L., Vesper, J., Volkmann, J., Groiss, S. J., Schnitzler, A., & Südmeyer, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.07.019 · Cited by 40
Li, W., Muftuler, L. T., Chen, G., Ward, B. D., Budde, M. D., Jones, J. L., Franczak, M. B., Antuono, P., Li, S., & Goveas, J. S. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.016 · Cited by 40
Tarumi, T., Thomas, B. P., Tseng, B. Y., Wang, C., Womack, K. B., Hynan, L. S., Lu, H., Cullum, C. M., & Zhang, R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190875 · Cited by 45
Alm, K. H., & Bakker, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181210 · Cited by 38
MR approaches in neurodegenerative disorders
Blamire, A. M. (2018) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2018.11.001 · Cited by 37
Hu, Z., Wang, L., Zhu, D., Qin, R., Sheng, X., Ke, Z., Shao, P., Zhao, H., Xu, Y., & Bai, F. (2023) · Brain Sciences · doi:10.3390/brainsci13030460 · Cited by 32
Chen, H., Sheng, X., Qin, R., Luo, C., Li, M., Liu, R., Zhang, B., Xu, Y., Zhao, H., & Bai, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.570123 · Cited by 30
Wang, X., Yu, Y., Zhao, W., Li, Q., Li, X., Li, S., Yin, C., & Han, Y. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00342 · Cited by 31
Disruption of thalamic connectivity in Alzheimer’s disease: a diffusion tensor imaging study
Zhu, Q., Bi, S., Yao, X.-T., Ni, Z., Li, Y., Chen, B., Fan, G., & Shang, X. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9708-7 · Cited by 30
Initiative, A. D. N., Schilling, L. P., Pascoal, T. A., Zimmer, E. R., Mathotaarachchi, S. S., Shin, M., Rieder, C. R. D. M., Gauthier, S. G., Palmini, A., & Rosa‐Neto, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1405-1 · Cited by 25
Yu, B., Shan, Y., & Ding, J. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-825 · Cited by 26
Vitamin D Deficiency Disrupts Neuronal Integrity in Cognitively Impaired Patients
Moon, Y., Moon, W., Kwon, H., Lee, J., & Han, S. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143063 · Cited by 25
Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer’s Disease
Roy, M., Rheault, F., Croteau, É., Castellano, C., Fortier, M., St‐Pierre, V., Houde, J., Turcotte, É. E., Bocti, C., Fülöp, T., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200213 · Cited by 23
Bazydlo, A., Zammit, M. D., Wu, M., Dean, D., Johnson, S. C., Tudorascu, D., Cohen, A. D., Cody, K. A., Ances, B. M., Laymon, C. M., et al. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09366-1 · Cited by 23
Kehoe, E. G., Farrell, D., Metzler‐Baddeley, C., LAWLOR, B. A., Kenny, R. A., Lyons, D., McNulty, J. P., Mullins, P. G., Coyle, D., & Bokde, A. L. W. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00010 · Cited by 24
Rabin, J. S., Perea, R. D., Buckley, R. F., Johnson, K. A., Sperling, R. A., & Hedden, T. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.05.005 · Cited by 24
He, X., Wu, B., Kuo, K., Zhang, W., Ma, Q., Xiang, S., Li, Y., Wang, Z.-Y., Dong, Q., Feng, J., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01256-z · Cited by 23
Connectome-derived diffusion characteristics of the fornix in Alzheimer's disease
Perea, R. D., Rabin, J. S., Fujiyoshi, M. G., Neal, T. E., Smith, E. E., Dijk, K. R. A. V., & Hedden, T. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.029 · Cited by 20
Initiative, A. D. N., Farrar, D. C., Mian, A. Z., Budson, A. E., Moss, M. B., Koo, B., & Killiany, R. (2017) · European Radiology · doi:10.1007/s00330-017-4951-4 · Cited by 21
Sali, D., Verganelakis, D. A., Gotsis, E. D., Toulas, P., Papatriantafillou, J., Karageorgiou, C. E., Thomaides, T., Kapsalaki, E. Z., Hadjigeorgiou, G. M., & Papadimitriou, A. (2013) · Acta Neurologica Belgica · doi:10.1007/s13760-013-0197-3 · Cited by 20
Hu, Z., Wu, L., Jia, J., & Han, Y. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1407-y · Cited by 20
Atlas-Based Diffusion Tensor Imaging Correlates of Executive Function
Nowrangi, M. A., Okonkwo, O., Lyketsos, C., Oishi, K., Mori, S., Albert, M., & Mielke, M. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141937 · Cited by 19
Bergamino, M., Keeling, E. G., Walsh, R. R., & Stokes, A. M. (2021) · Tomography · doi:10.3390/tomography7010003 · Cited by 19
Systems modeling of white matter microstructural abnormalities in Alzheimer's disease
Horgusluoglu, E., Xiao, G., Wang, M., Wang, Q., Zhou, X., Nho, K. T., Saykin, A. J., Schadt, E. E., & Zhang, B. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102203 · Cited by 19
Al-Khishman, N. U., Qi, Q., Roseborough, A. D., Levit, A., Allman, B. L., Anazodo, U., Fox, M. S., Whitehead, S. N., & Thiessen, J. D. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00699-x · Cited by 19
Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer’s Disease
Wang, J., Wang, P., Jiang, Y., Wang, Z., Zhang, H., Li, H., & Biswal, B. B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215239 · Cited by 18
Fornix degeneration in risk factors of Alzheimer's disease, possible trigger of cognitive decline
Lacalle‐Aurioles, M., & Iturria‐Medina, Y. (2023) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2023.100158 · Cited by 20
Shigemoto, Y., Sone, D., Maikusa, N., Okamura, N., Furumoto, S., Kudo, Y., Ogawa, M., Takano, H., Yokoi, Y., Sakata, M., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.1145 · Cited by 19
Gilligan, T. M., Sibilia, F., Farrell, D., Lyons, D., Kennelly, S., & Bokde, A. L. W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222977 · Cited by 13
Short‐term white matter alterations in Alzheimer's disease characterized by diffusion tensor imaging
Genc, S., Steward, C. E., Malpas, C. B., Velakoulis, D., O'Brien, T. J., & Desmond, P. M. (2015) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25017 · Cited by 14
Long Longitudinal Tract Lesion Contributes to the Progression of Alzheimer's Disease
Luo, C., Li, M., Qin, R., Chen, H., Huang, L., Yang, D., Ye, Q., Liu, R., Xu, Y., Zhao, H., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.503235 · Cited by 14
Reddan, J. M., Macpherson, H., White, D., Scholey, A. B., & Pipingas, A. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000185 · Cited by 15
Delvenne, J., Scally, B., & Burke, M. R. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137331 · Cited by 12
Marcolini, S., Rojczyk, P., Seitz‐Holland, J., Koerte, I. K., Alosco, M. L., & Sylvain Bouix, A. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221304 · Cited by 12
Diffusion characteristics of the fornix in patients with Alzheimer’s disease
Tang, S. X., Feng, Q., Wang, G. H., Duan, S., Shan, B., & Dai, J. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.09.012 · Cited by 12
Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging
Maharjan, S., Tsai, A. P., Lin, P. B., Ingraham, C., Jewett, M. R., Landreth, G. E., Oblak, A. L., & Wang, N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.964654 · Cited by 15
“Reduced FA and increased MD in hippocampus were reported in many of these human studies, probably attributed to increased extracellular space volume and neurodegeneration (Muller et al., 2007; Cherubini et al., 2010; Hong et al., 2013; Nowrangi et al., 2013).”
BackgroundXu, J., Yu, J., Gai, L., & Wang, Y. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1464159 · Cited by 12
Functional Imaging for Neurodegenerative Diseases
Chollet, F., & Payoux, P. (2022) · La Presse Médicale · doi:10.1016/j.lpm.2022.104121 · Cited by 11
Rajan, S., Brettschneider, J. A., & Collingwood, J. F. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108870 · Cited by 9
Altered white matter functional pathways in Alzheimer’s disease
Li, Y., Peng, J., Yang, Z., Zhang, F., Liu, L., Wang, P., & Biswal, B. B. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhad505 · Cited by 9
Initiative, A. D. N., Yu, J., & Lee, T. M. C. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00183-8 · Cited by 8
White matter microstructure associations to amyloid burden in adults with Down syndrome
Bazydlo, A., Zammit, M. D., Wu, M., Lao, P. J., Dean, D., Johnson, S. C., Tudorascu, D., Cohen, A. D., Cody, K. A., Ances, B. M., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102908 · Cited by 8
Liu, P., Liu, H., Wei, L., Shi, X., Wang, W., Yan, S., Zhou, W., Zhang, J., & Han, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1167425 · Cited by 7
Zhao, X., You, M., Ren, W., Ji, L., Liu, Y., & Lu, M. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1467578 · Cited by 7
Mechanism of cognitive impairment in chronic patients with putaminal hemorrhage
Yang, J.-H., Lee, H. D., Kwak, S., Byun, K. H., Park, S. H., & Yang, D. (2018) · Medicine · doi:10.1097/md.0000000000011035 · Cited by 6
Yu, Y., Zhao, W., Li, S., & Yin, C. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013432 · Cited by 6
A review of brain research on T2DM-related cognitive dysfunction
Liu, Q., Dai, S., Li, X., Chen, Y., Wang, N., Wu, J., Zhou, Y., Yan, B., Guo, Y., & Liu, Y. (2025) · Open Medicine · doi:10.1515/med-2025-1253 · Cited by 6
Xie, Y., Cai, K., Dai, J., & Wei, G. (2023) · Brain Sciences · doi:10.3390/brainsci13040691 · Cited by 4
Liu, J.-P., Han, B., Liu, Y., Nie, B., Bian, T., Liu, C., Xia, T.-Q., Gong, Y., Tu, L.-T., Zhang, J., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1637037 · Cited by 3
Collaborative Survival Analysis on Predicting Alzheimer’s Disease Progression
Xu, W., Wang, S., Shen, L., & Zhao, Y. (2024) · Statistics in Biosciences · doi:10.1007/s12561-024-09459-0 · Cited by 2
Diao, Y., Lanz, B., & Jelescu, I. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01328-0 · Cited by 2
Naming practice effects and inconsistencies relate to treatment outcome in people with aphasia
Wilmskoetter, J., Blackwood, K., Kristinsson, S., Walker, G. M., Fridriksson, J., Blackett, D. S., den Ouden, D., Rorden, C., Hillis, A. E., Hickok, G. S., et al. (2025) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2025.109271 · Cited by 2
Associations between APOE‐TOMM40 ‘523 haplotypes and limbic system white matter microstructure
Mooney, K. E., Archer, D. B., Sathe, A., Hohman, T. J., Kadiri, O., Lamar, M., Arfanakis, K., Yu, L., Barnes, L. L., & Deters, K. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70099 · Cited by 1
Yu, W. C., Guo, Y., Peng, J., Wang, C., Zhang, Z., Herrero, M. T., Tao, M., & Shu, Z. (2025) · Current Alzheimer Research · doi:10.2174/0115672050390986250801005607 · Cited by 1
Multilevel white matter degeneration associated cognitive dysfunction in mild cognitive impairment
Chen, Y., Liu, T.-T., Cao, L.-Z., Wang, L., Funahashi, S., Tang, X.-Y., Wu, J.-L., Meng, W., Zhang, J., & Yan, T.-Y. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03179-7 · Cited by 2
Filippi, M., Agosta, F., & Spinelli, E. G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3118-7_17
Development of magnetic resonance imaging techniques for mouse models of Alzheimer's Disease
O’Callaghan, J. M. (2015) · UCL Discovery (University College London)
Metadata
- Authors
- Nowrangi, M. A., Lyketsos, C. G., Leoutsakos, J. S., Oishi, K., Albert, M., Mori, S., & Mielke, M. M.
- Affiliations
- Johns Hopkins University (US)
- Mayo Clinic (US)
- Corresponding author
- Nowrangi, Milap A.
- ORCID
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2012-12-14
- Volume
- 9
- Issue
- 5
- Pages
- 519-528
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- PMC
- PMC3639296
- OpenAlex
- W2030309279
- Cited by
- 120
- References
- 64
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 5 · 2023: 11 · 2022: 3 · 2021: 7 · 2020: 13 · 2019: 11 · 2018: 12 · 2017: 6 · 2016: 7 · 2015: 16 · 2014: 7 · 2013: 5
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Alzheimer s & Dementia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- GlaxoSmithKline
- National Institute on Aging (P50-AG005146, P50-AG021334, R21 AG033774)
- National Institutes of Health (R21AG033774, P50AG005146)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- mild cognitive impairment, Alzheimer's disease
- MeSH terms
- Aged, Alzheimer Disease, Brain, Female, Humans, Image Interpretation, Computer-Assisted, Longitudinal Studies, Male, Nerve Fibers, Myelinated, Anisotropy, Diffusion Magnetic Resonance Imaging, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review